Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-13 Care Capital III LLC 10% owner Grant or award +30,793,670 30,793,670
2018-02-13 Markham Richard J Director Grant or award +30,793,670 30,793,670
2018-02-13 LESCHLY JAN Director Grant or award +30,793,670 30,793,670
2017-05-18 ANIDO ARMANDO Director Grant or award · Stock Option (Right to Buy) +20,000 $0.49 $10K 75,000
2017-05-18 COX GEOFFREY F Director Grant or award · Stock Option (Right to Buy) +20,000 $0.49 $10K 103,332
2017-05-18 DOUGHERTY MICHAEL R Director Grant or award · Stock Option (Right to Buy) +20,000 $0.49 $10K 105,000
2017-05-18 Dunne Michael W. Director Grant or award · Stock Option (Right to Buy) +20,000 $0.49 $10K 75,000
2017-05-18 Richard John P Director Grant or award · Stock Option (Right to Buy) +20,000 $0.49 $10K 105,000
2017-05-18 PLUMB RUSSELL H Director Grant or award · Stock Option (Right to Buy) +20,000 $0.49 $10K 622,453
2017-05-18 VANLENT ANNE Director Grant or award · Stock Option (Right to Buy) +20,000 $0.49 $10K 105,000
2017-04-03 COLONNESE MARK P Chief Financial Officer Grant or award · Stock Option (Right to Buy) +400,000 $0.66 $262K 775,000
2017-04-03 PATTI JOSEPH M CEO Grant or award · Stock Option (Right to Buy) +650,000 $0.66 $426K 2,113,304
2016-08-11 PATTI JOSEPH M CEO Grant or award · Stock Option (Right to Buy) +380,000 $1.30 $494K 1,478,929
2016-07-27 COLONNESE MARK P CFO and EVP Grant or award · Stock Option (Right to Buy) +150,000 $1.34 $201K 375,000
2016-05-12 ANIDO ARMANDO Director Grant or award · Stock Option (Right to Buy) +20,000 $1.50 $30K 20,000
2016-05-12 COX GEOFFREY F Director Grant or award · Stock Option (Right to Buy) +20,000 $1.50 $30K 20,000
2016-05-12 DOUGHERTY MICHAEL R Director Grant or award · Stock Option (Right to Buy) +20,000 $1.50 $30K 20,000
2016-05-12 Dunne Michael W. Director Grant or award · Stock Option (Right to Buy) +20,000 $1.50 $30K 20,000
2016-05-12 PLUMB RUSSELL H Director Grant or award · Stock Option (Right to Buy) +20,000 $1.50 $30K 20,000
2016-05-12 Richard John P Director Grant or award · Stock Option (Right to Buy) +20,000 $1.50 $30K 20,000

Page 22 of 23 · 442 trades